| Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion | Science | 2011 | 3.8K |
| Natural innate and adaptive immunity to cancer | Annual Review of Immunology | 2011 | 1.4K |
| Oncogenic Signaling Pathways in The Cancer Genome Atlas | Cell | 2018 | 1.1K |
| Comprehensive genomic profiles of small cell lung cancer | Nature | 2015 | 1.1K |
| Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome | Clinical Cancer Research | 2008 | 1K |
| Immune surveillance of tumors | Journal of Clinical Investigation | 2007 | 942 |
| Whole-genome characterization of chemoresistant ovarian cancer | Nature | 2015 | 890 |
| Completion Dissection or Observation for Sentinel-Node Metastasis in Melanoma | New England Journal of Medicine | 2017 | 739 |
| Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis | Lancet Oncology, The | 2017 | 492 |
| Anti-PD-1 antibody therapy potently enhances the eradication of established tumors by gene-modified T cells | Clinical Cancer Research | 2013 | 485 |
| Lymphangiogenesis and lymphatic vessel remodelling in cancer | Nature Reviews Cancer | 2014 | 467 |
| Breast cancer prognostic classification in the molecular era: the role of histological grade | Breast Cancer Research | 2010 | 459 |
| Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists | Modern Pathology | 2011 | 447 |
| Single-cell profiling of breast cancer T cells reveals a tissue-resident memory subset associated with improved prognosis | Nature Medicine | 2018 | 420 |
| Does lung adenocarcinoma subtype predict patient survival?: A clinicopathologic study based on the new International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society international multidisciplinary lung adenocarcinoma classification | Journal of Thoracic Oncology | 2011 | 411 |
| Pathology of breast and ovarian cancers among BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) | Cancer Epidemiology Biomarkers and Prevention | 2012 | 411 |
| GAPDH and autophagy preserve survival after apoptotic cytochrome c release in the absence of caspase activation | Cell | 2007 | 410 |
| Methylation-sensitive high resolution melting (MS-HRM): a new approach for sensitive and high-throughput assessment of methylation | Nucleic Acids Research | 2007 | 390 |
| Molecular and clinical analysis of locally advanced dermatofibrosarcoma protuberans treated with imatinib: Imatinib Target Exploration Consortium Study B2225 | Journal of Clinical Oncology | 2005 | 374 |
| Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy | Proceedings of the National Academy of Sciences of the United States of America | 2011 | 334 |
| Assessing Tumor-Infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method from the International Immuno-Oncology Biomarkers Working Group: Part 2: TILs in Melanoma, Gastrointestinal Tract Carcinomas, Non-Small Cell Lung Carcinoma and Mesothelioma, Endometrial and Ovarian Carcinomas, Squamous Cell Carcinoma of the Head and Neck, Genitourinary Carcinomas, and Primary Brain Tumors | Advances in Anatomic Pathology | 2017 | 299 |
| Persistence and efficacy of second generation CAR T cell against the LeY antigen in acute myeloid leukemia | Molecular Therapy | 2013 | 299 |
| Assessing Tumor-infiltrating Lymphocytes in Solid Tumors: A Practical Review for Pathologists and Proposal for a Standardized Method From the International Immunooncology Biomarkers Working Group: Part 1: Assessing the Host Immune Response, TILs in Invasive Breast Carcinoma and Ductal Carcinoma In Situ, Metastatic Tumor Deposits and Areas for Further Research | Advances in Anatomic Pathology | 2017 | 293 |
| Epigenetic profiling to classify cancer of unknown primary: a multicentre, retrospective analysis | Lancet Oncology, The | 2016 | 251 |
| Hyperactivation of Stat3 in gp130 mutant mice promotes gastric hyperproliferation and desensitizes TGF-beta signaling | Nature Medicine | 2005 | 251 |
